Month: March 2022

11 March 2022 Ad hoc announcement pursuant to Article 53 of SIX Exchange Regulation Listing Rules ONE swiss bank SA 2021 annual financial results in true and fair view “2021 was an intense and productive year during which ONE swiss bank accelerated its strategy of bringing together different entities to continue its growth and get closer to its profitability objectives. By putting together enthusiastic, like-minded and determined people, we successfully faced COVID-19’s challenges and kept moving forward to reach several major milestones, such as:completing three complex transactions in various forms (merger, asset deal and acquisition) onboarding hundreds of clients and welcomed tens of new colleagues opening offices in Zurich and Dubai expending our asset management capabilities under the brand Dynagest by ONE defining a concrete pathway...

DALLAS, TX, March 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Nubia Brand International Corp. (the “Company”) announced today that it priced its initial public offering of 11,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, March 11, 2022, under the ticker symbol “NUBIU”. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under...

LONDON, March 11, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for people with inherited systemic debilitating diseases, today announced that it has entered into a definitive agreement with Freeline’s majority shareholder, Syncona Portfolio Limited, a subsidiary of Syncona Limited, and certain other existing shareholders to purchase an aggregate of $26.1 million of its American Depositary Shares (“ADSs”), each representing one ordinary share of the Company, at a price of $1.05 per ADS, in a registered direct offering. The closing of the offering is expected to occur on or about March 15, 2022, subject to the satisfaction of customary closing conditions. Freeline intends to use...

IRVINE, Calif., March 10, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $81.00 per share, before underwriting discounts and commissions. In addition, Inari has granted the underwriters a 30-day option to purchase up to 300,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are to be sold by Inari. The offering is expected to close on or about March 15, 2022, subject to customary closing conditions. BofA Securities and Morgan Stanley are acting as joint...

‎ ‎NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR ‎DISSEMINATION ‎IN THE UNITED STATES TORONTO, March 10, 2022 (GLOBE NEWSWIRE) — BlueRush Inc. (“BlueRush” or ‎‎the “Company”) (TSXV:BTV; OTCQB: BTVRF), an emerging personalized video creation Software as a Service (“SaaS“) company, is pleased to announce that it has entered into an agreement with a U.S. registered securities broker dealer‎ ‎‎(the “Placement Agent”), ‎pursuant to which the Company will issue on a private placement basis (the “Offering“) ‎up to 100,000,000 units of the Company (the “Units“) at a price ‎of US$0.05 per Unit, for aggregate gross proceeds of up to US‎‎$5,000,000. Each Unit shall consist of (i) one (1) common share of the‎ ‎Company (the “Common Shares”), and (ii) one-half (1/2) of one transferable ‎Common...

VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV: AME) is pleased to announce the closing of the first tranche of its non-brokered private placement of units (the “Private Placement”), as announced on February 23, 2022, February 28, 2022 and March 2, 2022. Pursuant to the first tranche of the Private Placement, the Company raised total gross proceed of $700,000, and issued 11,666,667 units (“Units”) at a price of $0.06 per Unit. Each Unit consists of one common share of the Company (a “Share”) and one-half of one common share purchase warrant (a “Warrant”), with each full Warrant exercisable to purchase one Share at a price of $0.10 per Share until March 10, 2024. The Company also paid a total of $11,088 in cash commissions and issued a...

March 10, 2022 Amsterdam, the Netherlands – Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, today provided an update on the remediation status in the US of the ongoing recall of certain sleep and respiratory care products in connection with identified potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in these devices. Customer and patient outreach Following two rounds of comprehensive customer and patient outreach, Philips Respironics has reached the vast majority of the installed base in the US resulting in the registration of approximately 2.6 million devices in the country. Philips Respironics continues to monitor recall awareness for affected patients [1]. Philips Respironics is working cooperatively with the US Food and Drug Administration (FDA) to further increase...